Intrahepatic HBV DNA and covalently closed circular DNA (cccDNA) levels in patients positive for anti-HBc and negative for HBsAg

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 41, Issue 4, 2010, Pages 867-875

  Chaiteerakij, Roongruedee ^a   Komolmit, Piyawat ^a   Sa Nguanmoo, Pattaratida ^b   Poovorawan, Yong ^a,b  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Cccdna; HBV DNA; Hepatitis B virus; Real time PCR

Indexed keywords

CIRCULAR DNA; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; ASIAN; CASE CONTROL STUDY; FEMALE; GENETICS; HEPATITIS B; HUMAN; IMMUNOLOGY; LIVER; MALE; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; POLYMERASE CHAIN REACTION; SEROLOGY; THAILAND; VIROLOGY;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOPSY, FINE-NEEDLE; CASE-CONTROL STUDIES; DNA, CIRCULAR; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HUMANS; LIVER; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEROLOGIC TESTS; THAILAND; YOUNG ADULT;

EID: 79952111089     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ahn SH, Park YN, Park JY, et al. Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. J Hepatol 2005; 42: 188-94.
2. Caruntu FA, Molagic V. CccDNA persistence during natural evolution of chronic VHB infection. Rom J Gastroenterol 2005;14:373-7.
3. Dickson RC, Everhart JE, Lake JR, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1997; 113: 1668-74.
4. He ML, Wu J, Chen Y, et al. A new and sensitive method for the quantification of HBV cccDNA by real-time PCR. Biochem Biophys Res Commune 2002; 295: 1102-7.
5. Laras A, Koskinas J, Dimou E, Kostamena A, Hadziyannis SJ. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology 2006; 44: 694-702.
6. Lee WM. Hepaitits B virus infection. N Engl J Med 1997; 324: 1733-45.
7. Mason AL, Xu L, Guo L, et al. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 1998; 27: 1736-42.
8. Mindikoglu AL, Regev A, Schiff ER. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention. Clin Gastroenterol Hepatol 2006; 4: 1076-81.
9. Murakami Y, Minami M, Daimon Y, Okanoue T. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen. J Med Virol 2004; 72: 203-14.
10. Payungporn S, Tangkijvanich P, Jantaradsamee P, Theamboonlers A, Poovorawan Y. Simultaneous quantitation and genotyping of hepatitis B by real-time PCR and melting curve analysis. J Virol Methods 2004; 120: 131-40.
11. Raimondo G, Pollicino T, Cacciola I, et al. Occult hepatitis B virus infection. J Hepatol 2007; 46: 160-70.
12. Shadrina MI, Semenova EV, Slominsky PA, et al. Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage. BMC Med Genet 2007; 8: 6.
13. Theamboonlers A, Jantaradsamee P, Kaew-In N, et al. The predominant genotypes of hepatitis B virus in Thailand. Ann Trop Med Parasitol 1999; 93: 737-43.
14. Werle-Lapostolle B, Bowden S, Locarnini S, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004; 126: 1750-8.
15. Wong DK, Yuen MF, Poon RT, Yuen JC, Fung J, Lai CL. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. J Hepatol 2006; 45: 553-9.
16. Yuen MF, Wong DK, Fung J, et al. HBsAg seroclearance in chronic hepatitis B in Asian Patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 2008; 135: 1192-9.
17. Yuen MF, Wong DK, Sablon E, et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology 2004; 39: 1694-701.
18. Yuen MF, Wong DK, Sum SS, et al. Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection. Am J Gastroenterol 2005; 100: 1099-103.
19. Yuki N, Nagaoka T, Yamashiro M, et al. Longterm histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology 2003; 37: 1172-79.
20. Zoulim F. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol 2005; 42: 302-8.